Michael Marlatt

Michael Marlatt currently serves as the Director of the Disease Area Strategy Team at Daiichi Sankyo, Inc., beginning in November 2023. Prior to this role, Michael held various positions at Molekule Consulting LLC, where tenure included serving as President of Worldwide Research Operations and VP of Worldwide Research Operations from January 2017 to November 2023. Previous experience includes roles at Occam Global, Deallus Consulting, and a training program at the University of Amsterdam/National Institutes of Health. Michael began a career in the pharmaceutical industry as a Staff Biologist at Merck Sharp & Dohme from 2005 to 2008. Educational achievements include a PhD in Neuroscience from the University of Amsterdam (2012), an MSc in Pathology from Case Western Reserve University (2005), and a BSc in Biochemistry from Case Western Reserve University (2003).